Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effect of Moxonidine and Diet on Cardiac, Renal and Endothelial Function in Young Subjects With Abdominal Obesity

NCT01180231 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.

NCT NCT01180231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01180231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effect of Moxonidine and Diet on Cardiac, Renal and Endothelial Function in Young Subjects With Abdominal Obesity
Lead sponsor
Baker Heart and Diabetes Institute
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2010
Completion date
September 30, 2014
Enrollment
77 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight